Artiva Biotherapeutics, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
Mailing Address
5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
Phone
(858) 267-4467
Fiscal Year End
1231
EIN
863614316
Financial Overview
FY2025 FY
$251K
Revenue
$186.64M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 10-K Annual financial report | March 10, 2026 | View on SEC |
| 8-K Current report of material events | February 24, 2026 | View on SEC |
| 3 Initial insider ownership report | February 24, 2026 | View on SEC |
| 8-K Current report of material events | February 19, 2026 | View on SEC |
| 3 Initial insider ownership report | February 19, 2026 | View on SEC |
| 4 Insider stock transaction report | February 19, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
Annual Reports
10-K
March 10, 2026
- ARTIVA-001 successfully completed Phase 1 and initiated a Phase 2 study in Q3 2025, with positive preliminary safety and efficacy data presented.
- Ended 2025 with a strong cash position of $205.3 million, bolstered by a $75.0 million public offering, providing a cash runway into Q4 2026.
Insider Trading
SELL
1 insiders
1 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
MESOBLAST LTD
MESO
Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Scilex Holding Co
SCLX
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.